GlassScriptPhysician profile
Brian J Davis
NPI 1730150277
$27,613.15
in general payments reported to CMS, 2019-2025
11 companies · $1,554 in 2025
The $1,554 reported for 2025 was more than what 88% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,690 · 2020: $5,448 · 2021: $5,815 · 2022: $912 · 2023: $3,951 · 2024: $2,243 · 2025: $1,554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,413 · Food and Beverage: $3,113 · Travel and Lodging: $1,224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,412.50 |
| Food and Beverage | $3,112.52 |
| Travel and Lodging | $1,223.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $23,468.91 | 2019-2025 | Spaceoar Vue System - 10ml, Spaceoar System |
| Bioprotect Medical, INC. | $2,151.30 | 2024-2025 | Bioprotect Balloon Implant System |
| Theragenics Corporation | $1,017.89 | 2019-2025 | |
| Isoray, INC | $496.67 | 2022-2024 | Brachytherapy Source |
| Astellas Pharma US INC | $135.48 | 2024-2025 | Xtandi |
| Elekta, INC. | $134.26 | 2024 | |
| Teleflex LLC | $94.65 | 2024-2025 | Barrigel |
| Blue Earth Diagnostics | $36.25 | 2019 | |
| Pfizer INC. | $29.78 | 2025 | |
| Novartis Pharmaceuticals Corporation | $27.69 | 2022 | |
| Sumitomo Pharma America, INC. | $20.27 | 2024 | Orgovyx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.